Biogen Inc.
Price · 20 sessions
$216.90+18.26%Signal status
Score breakdown · 20D
12:33 PM · 15 minutes agoUpdated 12:33 PM (New York, ET) · 15 minutes ago
Source: yahoo-financeCurrent market state
stock
Signal History
No history yet. Appears after admin saves daily snapshots.
News
Biogen: Key Takeaways From Needham’s Meeting With Top Management
Biogen: Key Takeaways From Needham’s Meeting With Top Management Benzinga
Biogen (BIIB) Moves 7.0% Higher: Will This Strength Last?
Biogen (BIIB) Moves 7.0% Higher: Will This Strength Last? Yahoo Finance
Biogen puts Alzheimer’s pipeline on display at AAIC 2026
Biogen puts Alzheimer’s pipeline on display at AAIC 2026 Stock Titan
BIIB Maintained by Needham -- Price Target Raised to $256
BIIB Maintained by Needham -- Price Target Raised to $256 GuruFocus
New Analyst Forecast: $BIIB Given $256 Price Target
New Analyst Forecast: $BIIB Given $256 Price Target Quiver Quantitative
Biogen (BIIB) Is Up 9.9% After US$1 Billion RayThera Deal And Salanersen Win - Has The Bull Case Changed?
Biogen (BIIB) Is Up 9.9% After US$1 Billion RayThera Deal And Salanersen Win - Has The Bull Case Changed? simplywall.st
BIIB Stock: Biogen Strengthens Immunology Pipeline In Up To $1B RayThera Deal
BIIB Stock: Biogen Strengthens Immunology Pipeline In Up To $1B RayThera Deal Stocktwits
Why Biogen (BIIB) Stock Is Up Today
Why Biogen (BIIB) Stock Is Up Today Yahoo Finance
Biogen Inc. stock outperforms competitors on strong trading day
Biogen Inc. stock outperforms competitors on strong trading day MarketWatch
Biogen stock reaches 52-week high at 206.21 USD
Biogen stock reaches 52-week high at 206.21 USD Investing.com
Biogen Stock (BIIB) Opinions on Congressional Purchases and Analyst Upgrade
Biogen Stock (BIIB) Opinions on Congressional Purchases and Analyst Upgrade Moomoo
Biogen Completes Acquisition of Apellis Pharmaceuticals
Biogen Completes Acquisition of Apellis Pharmaceuticals Biogen